TY - JOUR
T1 - Asthma prescribing, ethnicity and risk of hospital admission
T2 - An analysis of 35,864 linked primary and secondary care records in East London
AU - Hull, Sally A.
AU - McKibben, Shauna
AU - Homer, Kate
AU - Taylor, Stephanie Jc
AU - Pike, Katy
AU - Griffiths, Chris
PY - 2016/8/18
Y1 - 2016/8/18
N2 - Inappropriate prescribing in primary care was implicated in nearly half of asthma deaths reviewed in the UK's recent National Review of Asthma Deaths. Using anonymised EMIS-Web data for 139 ethnically diverse general practices (total population 942,511) extracted from the North and East London Commissioning Support Unit, which holds hospital Secondary Uses Services (SUS)-linked data, we examined the prevalence of over-prescribing of short-Acting β 2-Agonist inhalers (SABA), under-prescribing of inhaled corticosteroid (ICS) inhalers and solo prescribing of long-Acting β 2-Agonists (LABA) to assess the risk of hospitalisation for people with asthma for 1 year ending August 2015. In a total asthma population of 35,864, multivariate analyses in adults showed that the risk of admission increased with greater prescription of SABA inhalers above a baseline of 1-3 (4-12 SABA: odds ratio (OR) 1.71; 95% confidence interval (CI) 1.20-2.46, â
AB - Inappropriate prescribing in primary care was implicated in nearly half of asthma deaths reviewed in the UK's recent National Review of Asthma Deaths. Using anonymised EMIS-Web data for 139 ethnically diverse general practices (total population 942,511) extracted from the North and East London Commissioning Support Unit, which holds hospital Secondary Uses Services (SUS)-linked data, we examined the prevalence of over-prescribing of short-Acting β 2-Agonist inhalers (SABA), under-prescribing of inhaled corticosteroid (ICS) inhalers and solo prescribing of long-Acting β 2-Agonists (LABA) to assess the risk of hospitalisation for people with asthma for 1 year ending August 2015. In a total asthma population of 35,864, multivariate analyses in adults showed that the risk of admission increased with greater prescription of SABA inhalers above a baseline of 1-3 (4-12 SABA: odds ratio (OR) 1.71; 95% confidence interval (CI) 1.20-2.46, â
UR - http://www.scopus.com/inward/record.url?scp=84983250959&partnerID=8YFLogxK
U2 - 10.1038/npjpcrm.2016.49
DO - 10.1038/npjpcrm.2016.49
M3 - Article (Academic Journal)
C2 - 27537194
AN - SCOPUS:84983250959
SN - 2055-1010
VL - 26
JO - npj Primary Care Respiratory Medicine
JF - npj Primary Care Respiratory Medicine
M1 - 16049
ER -